Outcomes of isolated tricuspid valve replacement: a systematic review and meta-analysis of 5,316 patients from 35 studies

Contemporary insights into the epidemiology, impact and treatment of secondary tricuspid regurgitation across the heart failure spectrum

“…Despite these adverse outcomes, secondary TR (sTR) is often perceived as an epiphenomenon exclusively reflecting the underlying ventricular disease and therefore often not mandating therapy to reduce volume overload 5 . In addition, conservative guideline recommendations for surgical treatment reflect the associated excessive risk in these patients 6,7 due to the underlying ventricular damage, the high comorbidity burden and often systemic involvement 8 …”

“…5 In addition, conservative guideline recommendations for surgical treatment reflect the associated excessive risk in these patients 6,7 due to the underlying ventricular damage, the high comorbidity burden and often systemic involvement. 8 The true extent, impact and unmet treatment demand in sTR, however, remain unknown. Yet is crucial to assess and monitor the associated challenges for caregivers, public health authorities and service payers.…”

Is It Possible to Place a Pacemaker Lead Through a Bileaflet Mechanical Prosthesis?

“…Tricuspid valve (TV) replacement is a high-risk procedure with operative mortality rates between 10% and 16%. 1,2 One of the most common complications is heart block requiring a pacemaker, which occurs in about 10% of patients. 2 In most patients with mechanical prostheses in the tricuspid position, it is a challenge to place a pacemaker.…”

“…1,2 One of the most common complications is heart block requiring a pacemaker, which occurs in about 10% of patients. 2 In most patients with mechanical prostheses in the tricuspid position, it is a challenge to place a pacemaker. We present a patient with third-degree atrioventricular block (AVB) who underwent placement of a transvenous pacemaker through a bileaflet mechanical prosthesis.…”

A comprehensive overview of surgical and transcatheter therapies to treat tricuspid regurgitation in patients with heart failure

“…Unfortunately, adverse RV remodeling from chronic TR begets more TR as the tricuspid valve (TV) annulus dilates. Patients who are evaluated for functional TR interventions often manifest vague initial symptoms and tend to present late in their disease course with long-standing systemic congestion involving the hepatic, gastrointestinal, and renal systems [5,6]. Even in the modern era, isolated TV surgery harbors in-hospital mortality rates of 8-10%, which has not changed despite increasing surgical volume from heightened awareness of needing to treat TR [5,7,8].…”